A vaccine review panel has recommended that the Food and Drug Administration issue a second emergency use authorisation for the Covid-19 vaccine made by Moderna.
The panel members voted 20-0 in approval, with one abstention.
They believed the vaccine is safe enough for people over the age of 18 and that the benefits outweigh the risk for emergency use authorisation.
The panel held a day-long meeting to discuss safety, efficacy and other concerns before voting on the recommendation.
The move marks the huge scientific accomplishment of producing and gaining approval for two vaccines against a virus that was discovered only about a year ago.
It is expected that the full FDA will follow the panel's ruling and reports say the agency's approval could come as early as Friday.
After FDA approval, the Centres for Disease Control and Prevention will vote this weekend.
The vaccine can then be distributed to frontline healthcare workers and nursing home residents.
The FDA and the CDC approved emergency use of the Pfizer-BioNTech vaccine a week ago, making it the first Covid-19 vaccine approved in the US.
Immunisations started at the beginning of this week.
The vaccine is also being used in the UK, Canada, Saudi Arabia and other countries, and is awaiting approval for use in the EU.
The Moderna and Pfizer vaccines require two doses, although the Moderna vaccine can be stored in normal freezers and does not need to be moved in super-cold refrigerators like the Pfizer vaccine.
The company's vaccine was developed in collaboration with the National Institutes of Health.
The Pfizer-BioNTech vaccine was recommended for approval after the deadliest day in the US pandemic.
The Moderna vaccine was approved after more than 3,700 people died in the past 24 hours from Covid-19, Johns Hopkins University says.
More than 200,000 cases are recorded each day in the US and healthcare systems are reporting a record number of people with the virus in hospitals.
It is expected that holiday travel and gatherings for Christmas and the New Year will lead to further cases.
The US government has ordered 200 million doses from Moderna.
The company says it will try to make 50 million doses available for 25 million people before the end of December.
The%20specs%3A%202024%20Mercedes%20E200
%3Cp%3E%3Cstrong%3EEngine%3A%20%3C%2Fstrong%3E2.0-litre%20four-cyl%20turbo%20%2B%20mild%20hybrid%0D%3Cbr%3E%3Cstrong%3EPower%3A%20%3C%2Fstrong%3E204hp%20at%205%2C800rpm%20%2B23hp%20hybrid%20boost%0D%3Cbr%3E%3Cstrong%3ETorque%3A%20%3C%2Fstrong%3E320Nm%20at%201%2C800rpm%20%2B205Nm%20hybrid%20boost%0D%3Cbr%3E%3Cstrong%3ETransmission%3A%20%3C%2Fstrong%3E9-speed%20auto%0D%3Cbr%3E%3Cstrong%3EFuel%20consumption%3A%20%3C%2Fstrong%3E7.3L%2F100km%0D%3Cbr%3E%3Cstrong%3EOn%20sale%3A%20%3C%2Fstrong%3ENovember%2FDecember%0D%3Cbr%3E%3Cstrong%3EPrice%3A%20%3C%2Fstrong%3EFrom%20Dh205%2C000%20(estimate)%3C%2Fp%3E%0A
The%C2%A0specs%20
%3Cp%3E%0D%3Cstrong%3EEngine%3A%20%3C%2Fstrong%3E6-cylinder%2C%204.8-litre%20%0D%3Cbr%3E%3Cstrong%3ETransmission%3A%20%3C%2Fstrong%3E5-speed%20automatic%20and%20manual%0D%3Cbr%3E%3Cstrong%3EPower%3A%20%3C%2Fstrong%3E280%20brake%20horsepower%20%0D%3Cbr%3E%3Cstrong%3ETorque%3A%20%3C%2Fstrong%3E451Nm%20%0D%3Cbr%3E%3Cstrong%3EPrice%3A%20%3C%2Fstrong%3Efrom%20Dh153%2C00%0D%3Cbr%3E%3Cstrong%3EOn%20sale%3A%20%3C%2Fstrong%3Enow%3C%2Fp%3E%0A
Results:
First Test: New Zealand 30 British & Irish Lions 15
Second Test: New Zealand 21 British & Irish Lions 24
Third Test: New Zealand 15 British & Irish Lions 15
Rooney's club record
At Everton Appearances: 77; Goals: 17
At Manchester United Appearances: 559; Goals: 253
Email sent to Uber team from chief executive Dara Khosrowshahi
From: Dara
To: Team@
Date: March 25, 2019 at 11:45pm PT
Subj: Accelerating in the Middle East
Five years ago, Uber launched in the Middle East. It was the start of an incredible journey, with millions of riders and drivers finding new ways to move and work in a dynamic region that’s become so important to Uber. Now Pakistan is one of our fastest-growing markets in the world, women are driving with Uber across Saudi Arabia, and we chose Cairo to launch our first Uber Bus product late last year.
Today we are taking the next step in this journey—well, it’s more like a leap, and a big one: in a few minutes, we’ll announce that we’ve agreed to acquire Careem. Importantly, we intend to operate Careem independently, under the leadership of co-founder and current CEO Mudassir Sheikha. I’ve gotten to know both co-founders, Mudassir and Magnus Olsson, and what they have built is truly extraordinary. They are first-class entrepreneurs who share our platform vision and, like us, have launched a wide range of products—from digital payments to food delivery—to serve consumers.
I expect many of you will ask how we arrived at this structure, meaning allowing Careem to maintain an independent brand and operate separately. After careful consideration, we decided that this framework has the advantage of letting us build new products and try new ideas across not one, but two, strong brands, with strong operators within each. Over time, by integrating parts of our networks, we can operate more efficiently, achieve even lower wait times, expand new products like high-capacity vehicles and payments, and quicken the already remarkable pace of innovation in the region.
This acquisition is subject to regulatory approval in various countries, which we don’t expect before Q1 2020. Until then, nothing changes. And since both companies will continue to largely operate separately after the acquisition, very little will change in either teams’ day-to-day operations post-close. Today’s news is a testament to the incredible business our team has worked so hard to build.
It’s a great day for the Middle East, for the region’s thriving tech sector, for Careem, and for Uber.
Uber on,
Dara
